丹红注射液治疗中风心脑血管的临床合理应用  

Danhong Injection in the Treatment of Cardiovascular and Cerebrovascular Stroke Clinical Reasonable Application

作　　者：郭立忠[1] 

机构地区：[1]长春中医药大学附属医院,130021

出　　处：《中国卫生标准管理》2015年第29期128-129,共2页China Health Standard Management

摘　　要：目的观察丹红注射液在治疗中风心脑血管中的临床效果。方法选取2013年1月~2014年1月接受了丹红注射液治疗的50例患有中风心脑血管疾病的患者,对他们在治疗过程中的临床效果进行观察。结果在50例患有中风心脑血管患者采用丹红注射液治疗的过程中,其痊愈的效果明显,且并没有发现明显的并发症以及后遗症。结论在临床治疗上,丹红注射液是一种无毒无害的复方制剂,对于冠心病、心绞痛、心力衰竭以及脑梗死等疾病的治疗效果良好,并且能够有效的降低心脑血管患者在治疗过程中以及治疗之后的并发症的发生率,是现代临床治疗上普遍采用的一种治疗中风心脑血管疾病的一种方法。Objective To observe the effect of Danhong injection in the treatment of stroke in the treatment of cardiovascular clinical results. Methods I hospital in January 2013 ~ January 2014 received Danhong injection treatment 50 patients who had a stroke in patients with cardiovascular disease, on their clinical effects were observed during the treatment. Results In 50 cases of stroke in patients with vascular heart brain adoption process Danhong injection therapy, its healing effect is obvious, and found no significant complications and sequelae. Conclusion In the clinical treatment, Danhong injection is a non-toxic compound, for the treatment of coronary heart disease, angina, heart failure and cerebral infarction and other diseases is very significant, and can effectively reduce cardiovascular patients In the course of treatment and the incidence of complications after treatment, it is a method of treating cardiovascular and cerebrovascular diseases, stroke modern clinical treatment widely used.

关 键 词：丹红注射液 中风治疗 心脑血管 临床应用 

分 类 号：R282.707[医药卫生—中药学]